Pfizer Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 631.66 | 604.70 | 621.76 |
| Operating Expense | 399.34 | 385.37 | 357.20 |
| Net Profit | 158.35 | 150.71 | 178.86 |
| Net Profit Margin | 25.07 | 24.92 | 28.77 |
| Earning Per Share | 34.61 | 32.94 | 39.09 |
| EBIDTA | 235.33 | 222.47 | 248.25 |
| Effective Tax Rate | 25.78 | 25.10 | 18.40 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 631.66 |
| Operating Expense | 399.34 |
| Net Profit | 158.35 |
| Net Profit Margin | 25.07 |
| Earning Per Share | 34.61 |
| EBIDTA | 235.33 |
| Effective Tax Rate | 25.78 |
Invest in Pfizer Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 2,193.17 | 2,424.76 | 2,610.99 |
| Operating Expenses Annual | 1,557.87 | 1,615.90 | 1,775.26 |
| Operating Profit Annual | 823.76 | 942.91 | 898.38 |
| Interest Annual | 15.41 | 13.39 | 10.49 |
| Depreciation | 52.32 | 55.19 | 64.68 |
| Net Profit Annual | 551.33 | 623.93 | 612.56 |
| Tax Annual | 194.74 | 200.08 | 160.33 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 2,193.17 |
| Operating Expenses Annual | 1,557.87 |
| Operating Profit Annual | 823.76 |
| Interest Annual | 15.41 |
| Depreciation | 52.32 |
| Net Profit Annual | 551.33 |
| Tax Annual | 194.74 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 36.60 | 62.76 | 151.21 |
| Cash Flow from Operations | 256.84 | 355.68 | 667.08 |
| Cash Flow from Investing | 53.70 | -36.05 | -575.02 |
| Cash Flow from Financing | -235.14 | -345.79 | -180.51 |
| Cash Flow at the End | 112 | 36.60 | 62.76 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 36.60 |
| Cash Flow from Operations | 256.84 |
| Cash Flow from Investing | 53.70 |
| Cash Flow from Financing | -235.14 |
| Cash Flow at the End | 112 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 37.56 | 38.89 | 34.42 |
| PBIT Margin (%) | 34.72 | 34.54 | 30.01 |
| PBT Margin (%) | 32.47 | 31.98 | 27.21 |
| Net PROFIT Margin (%) | 25.14 | 25.73 | 23.46 |
| Return On Networth / Equity (%) | 16.21 | 20.55 | 23.30 |
| Return On Networth /Employed (%) | 21.43 | 25.88 | 27.78 |
| Return On Assets (%) | 15.59 | 19.30 | 21.82 |
| Total Debt / Equity (X) | 0.01 | 0.01 | 0.02 |
| Asset Turnover Ratio (%) | 0.62 | 0.75 | 0.93 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 37.56 |
| PBIT Margin (%) | 34.72 |
| PBT Margin (%) | 32.47 |
| Net PROFIT Margin (%) | 25.14 |
| Return On Networth / Equity (%) | 16.21 |
| Return On Networth /Employed (%) | 21.43 |
| Return On Assets (%) | 15.59 |
| Total Debt / Equity (X) | 0.01 |
| Asset Turnover Ratio (%) | 0.62 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 712.71 | 749.25 | 840.96 |
| Total Current Assets Annual | 2,737.81 | 2,493.34 | 2,396.48 |
| Non Current Assets Annual | 1,459.22 | 1,475.64 | 1,504.03 |
| Total Shareholders Funds Annual | 3,595.54 | 3,207.30 | 2,864.41 |
| Total Assets Annual | 4,228.78 | 4,000.73 | 3,900.51 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 712.71 |
| Total Current Assets Annual | 2,737.81 |
| Non Current Assets Annual | 1,459.22 |
| Total Shareholders Funds Annual | 3,595.54 |
| Total Assets Annual | 4,228.78 |
No Data Availabe
